Table I.
Example Parenteral Formulations Marketed in PFS and Vials
| Drug | Generic name | Buffer | pH | Container |
|---|---|---|---|---|
| Neulasta | Pegfilgrastim | Acetate | 4.0 | PFS |
| Humira | Adalimumab | Phosphate, citrate | 5.2 | PFS |
| Avastin | Bevacizumab | Phosphate | 6.2 | Vial |
| Enbrel | Etanercept | Phosphate | 6.3 | PFS |
| Rituxan | Rituximab | Citrate | 6.5 | Vial |
| Epogen | Epoetin alfa | Citrate or citrate, phosphate | 6.1 or 6.9 | Vial |
| Bacteriostatic water | Bacteriostatic water for injection | N/A | 4.5–7.0 | Vial |
| Acetadote | Acetylcysteine injection | N/A | 6.0–7.5 | Vial |
| Sodium bicarbonate | Sodium bicarbonate 5% injection | Carbonate | 7.0–8.5 | Vial |